Pricing and reimbursement in Japan: multiple modes of entry in a fragmented market
This article was originally published in Clinica
Executive Summary
With its high level of healthcare expenditure and a willingness to invest in innovative medical technologies, Japan represents a potentially lucrative market for medtech companies. In this article, consultants* at GfK Bridgehead aim to demystify Japan's notoriously complex regulatory and reimbursement systems and provide case studies of how to access the world's second largest medical device market